Big Pharma Split Stock Alpha and Beta Analysis
| PRM Stock | CAD 13.30 0.18 1.37% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Big Pharma Split. It also helps investors analyze the systematic and unsystematic risks associated with investing in Big Pharma over a specified time horizon. Remember, high Big Pharma's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Big Pharma's market risk premium analysis include:
Beta 0.0068 | Alpha (0.15) | Risk 1.02 | Sharpe Ratio (0.13) | Expected Return (0.13) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Big |
Big Pharma Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Big Pharma market risk premium is the additional return an investor will receive from holding Big Pharma long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Big Pharma. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Big Pharma's performance over market.| α | -0.15 | β | 0.01 |
Big Pharma expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Big Pharma's Buy-and-hold return. Our buy-and-hold chart shows how Big Pharma performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Big Pharma Market Price Analysis
Market price analysis indicators help investors to evaluate how Big Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Big Pharma shares will generate the highest return on investment. By understating and applying Big Pharma stock market price indicators, traders can identify Big Pharma position entry and exit signals to maximize returns.
Big Pharma Return and Market Media
The median price of Big Pharma for the period between Mon, Sep 2, 2024 and Sun, Dec 1, 2024 is 14.21 with a coefficient of variation of 3.86. The daily time series for the period is distributed with a sample standard deviation of 0.54, arithmetic mean of 13.92, and mean deviation of 0.49. The Stock received some media coverage during the period. Price Growth (%) |
| Timeline |
1 | Prediction This Will be Eli Lillys Next Big Move. - The Motley Fool | 09/19/2024 |
2 | Prediction Vertex Pharmaceuticals Could Be The Next Stock Split Stock - 247 Wall St. | 10/31/2024 |
3 | Harvest Declares Big Pharma Split Corp. November 2024 Distribution - Yahoo Finance | 11/22/2024 |
About Big Pharma Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Big or other stocks. Alpha measures the amount that position in Big Pharma Split has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2021 | 2022 (projected) | Dividend Yield | 0.12 | 0.0848 | Price To Sales Ratio | 3.53 | 5.93 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Big Pharma in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Big Pharma's short interest history, or implied volatility extrapolated from Big Pharma options trading.
Build Portfolio with Big Pharma
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Other Information on Investing in Big Stock
Big Pharma financial ratios help investors to determine whether Big Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Big with respect to the benefits of owning Big Pharma security.